Novel pharmacotherapies for heart failure

Keyphrases

• Heart Failure 100%
• Heart Failure with Preserved Ejection Fraction (HFpEF) 100%
• Neurohormonal 100%
• Guideline-directed Medical Therapy 100%
• Preserved EF 100%
• Novel Pharmacotherapy 100%
• Pathophysiology 50%
• Clinical Syndromes 50%
• Mortality Rate 50%
• Diastolic Dysfunction 50%
• Treatment Strategy 50%
• Novel Mechanism of Action 50%
• Human Studies 50%
• Blocking Agent 50%
• Heart Failure Treatment 50%
• Left Ventricular Remodeling 50%
• Pharmacological Treatment 50%
• Heart Failure Management 50%
• Therapeutic Advances 50%
• Disease Trajectory 50%
• Pre-clinical and Clinical Trials 50%
• Emerging Therapies 50%
• Pharmacologic Management 50%
• Emerging Pharmacotherapy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Pharmacotherapy 100%
• Heart Failure with Reduced Ejection Fraction 75%
• Combination Therapy 50%
• Clinical Trial 25%
• Mortality Rate 25%
• Pathophysiology 25%
• Syndrome 25%
• Human Study 25%
• Diastolic Dysfunction 25%
• Heart Ventricle Remodeling 25%
• Blocking Agent 25%
• Diseases 25%